Abstract
Objectives: Metachromatic leukodystrophy (MLD) has characteristic white matter (WM) changes on brain MRI, which often trigger biochemical and genetic confirmation of the diagnosis. In early or pre-symptomatic disease stages, these typical MRI changes might be absent, hampering early diagnosis. This study aims to describe the characteristics of MRI WM abnormalities at diagnosis, related to clinical presentation. Methods: We retrospectively reviewed brain MRIs of MLD patients followed in 2 centers at the time of diagnosis regarding MLD MRI score and presence of tigroid pattern. In addition, MLD subtype, symptom status, CNS/PNS phenotype, motor/cognitive/mixed phenotype, and the presence of CNS symptoms were evaluated. Results: We included 104 brain MRIs from patients with late-infantile (n = 43), early-juvenile (n = 24), late-juvenile (n = 20) and adult (n = 17) onset. Involvement of the corpus callosum was a characteristic early MRI sign and was present in 71% of the symptomatic late-infantile patients, 94% of the symptomatic early-juvenile patients and 100% of the symptomatic late-juvenile and adult patients. Symptomatic early-juvenile, late-juvenile and adult patients generally had WM abnormalities on MRI suggestive of MLD. By contrast, 47% of the early-symptomatic late-infantile patients had no or only mild WM abnormalities on MRI, even in the presence of CNS symptoms including pyramidal signs. Interpretation: Patients with late-infantile MLD may have no or only mild, nonspecific abnormalities at brain MRI, partly suggestive of ‘delayed myelination’, even with clear clinical symptoms. This may lead to significant diagnostic delay. Knowledge of these early MRI signs (or their absence) is important for fast diagnosis.
Original language | English |
---|---|
Pages (from-to) | 1999-2009 |
Number of pages | 11 |
Journal | Annals of Clinical and Translational Neurology |
Volume | 9 |
Issue number | 12 |
Early online date | 5 Nov 2022 |
DOIs | |
Publication status | Published - Dec 2022 |
Bibliographical note
Funding Information:SG was supported by DFG grant GR 4688/2‐1.
Funding Information:
The following authors of this publication are members of the European Reference Network for Rare Neurological Diseases (ERN-RND) – Project ID No 739510: S. Groeschel, M.S. van der Knaap, I. Krägeloh-Mann, N.I. Wolf. SG was supported by DFG grant GR 4688/2-1.
Publisher Copyright:
© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Funding
SG was supported by DFG grant GR 4688/2‐1. The following authors of this publication are members of the European Reference Network for Rare Neurological Diseases (ERN-RND) – Project ID No 739510: S. Groeschel, M.S. van der Knaap, I. Krägeloh-Mann, N.I. Wolf. SG was supported by DFG grant GR 4688/2-1.
Funders | Funder number |
---|---|
ERN-RND | 739510 |
Deutsche Forschungsgemeinschaft | GR 4688/2‐1 |
Deutsche Forschungsgemeinschaft |